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Plaques containing fibrillar amyloid-beta (Abeta) are a
characteristic finding in Alzheimer’s disease. Although plaque
counts correlate poorly with the extent of cognitive deficits in
this disorder, fibrillar Abeta can promote neuronal damage
through a variety of mechanisms. External beam radiotherapy
has been reported to be an effective treatment for tracheobron-
chial amyloidosis, in which amyloid is deposited as submucosal
plaques and tumor-like masses in the trachea and/or bronchi.
Radiotherapy’s effectiveness in this disorder is thought to be due
to its toxicity to plasma cells, but direct effects of radiotherapy
on amyloid may also be involved. On this basis, whole-brain
radiotherapy has been suggested as a treatment for Alzheimer’s
disease. The objective of this study was to determine the effects
of external beam radiation on preformed Abeta1-42 fibrils and
on the formation of these fibrils. Using the Thioflavin-T assay,
no effects of radiation were found on either of these parameters.
Our results in this in vitro study suggest that whole-brain
irradiation is unlikely to directly reduce plaque counts in the
Alzheimer’s disease brain. This treatment might still lower
plaque counts indirectly, but any potential benefits would need to
be weighed against its possible neurotoxic effects, which could
induce further cognitive deficits. g 2011 by Radiation Research Society
INTRODUCTION
Amyloid-beta (Ab), a 4.5-kDa peptide produced by
cleavage of amyloid precursor protein (APP), is the main
component of senile plaques in the Alzheimer’s disease
(AD) brain. Plaques and neurofibrillary tangles (NFT)
are the hallmark pathological findings in the AD brain.
The ‘‘amyloid hypothesis,’’ as originally proposed,
suggested that increased expression and deposition of
Ab in the brain precedes the processes such as
inflammation, oxidative stress, NFT formation and
neuronal loss that are thought to result in AD-related
cognitive impairment (1). However, this hypothesis was
difficult to reconcile with many studies indicating that
plaque counts are weakly correlated with the extent of
dementia in AD patients (2–8); in fact, some individuals
with high plaque loads have apparently normal cogni-
tion (9–12). A similar ‘‘disconnect’’ between memory
and Ab deposition was reported in the Tg2576 (Swedish
mutation) amyloid precursor protein (APP) transgenic
mouse model of AD; in a combined group of old and
young Tg2576 mice, there was no obvious correspon-
dence between spatial reference memory and insoluble
Ab (13). Ab has become the main target for AD
immunotherapy, although concerns have been expressed
that it may not be an appropriate target (14). Recent
therapeutic strategies for AD have included vaccination
with Ab (15), administration of a ‘‘humanized’’ mouse
anti-Ab monoclonal antibody (16), and inhibition of the
amyloidogenic pathway of APP (17). Thus far these
efforts have not been successful. The amyloid hypothesis
has been modified to reflect current thinking that soluble
aggregates of Ab, termed Ab soluble oligomers, rather
than plaque-associated fibrillar Ab, may initiate the
sequence of pathological events leading to AD-type
dementia (18, 19). This modified hypothesis is supported
by the recent finding that when synthetic Ab1-42
oligomers were injected into the cerebral ventricles of
young C57BL/6 mice, immediate short-term memory
impairment occurred, whereas this effect was not seen
when Ab1-42 fibrils or freshly dissolved Ab1-42 was
injected (20).
Several studies have reported external beam radio-
therapy to be an effective treatment for tracheobronchial
amyloidosis (TBA), a rare condition in which amyloid is
deposited in the trachea and bronchi as submucosal
plaques and/or tumor-like masses (21–24). The amyloid
in TBA is thought to result from excessive production of
immunoglobulin light chains by plasma cells in the
tracheobronchial tree (25, 26). The mechanism by which
1 Address for correspondence: William Beaumont Hospital Re-
search Institute, 3811 West Thirteen Mile Road, Royal Oak, MI
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radiotherapy reduces the amyloid deposits in this
disorder may therefore involve radiation-induced dam-
age to these plasma cells, which are reported to be
radiosensitive (27, 28). Additional mechanisms suggest-
ed to account for radiotherapy’s effectiveness against
TBA include direct degradation of amyloid, an increase
in amyloid clearance, and/or damage to the local
vasculature (21, 24, 29). On this basis, whole-brain
irradiation has been proposed as a treatment for AD
(29). Surprisingly, a literature search found no studies of
the effects of external beam radiation on Ab, although
extensive laser irradiation was reported to destroy
preformed Ab fibrils (30). The objective of this
investigation was therefore to determine the effects of
radiation on preformed Ab1-42 fibrils and on the
development of these fibrils.
MATERIALS AND METHODS
Disaggregation of Ab
Ab1-42 (0.5 mg; AnaSpec, San Jose, CA) was disaggregated by
resuspending in 0.25 ml trifluoroacetic acid (FA, Sigma-Aldrich, Inc.,
St. Louis, MO) followed by hexafluoro-2-propanol (Sigma-Aldrich).
It was divided into aliquots in eppitubes (20 ml/tube), dried overnight
(16–20 h) at room temperature in the fume hood, and stored at
220uC. Total protein measurement (Bio-Rad Protein Assay, Bio-Rad
Laboratories, Hercules, CA) indicated that each tube contained
approximately 10.8 mg of Ab.
Western Blot
Western blotting was performed to confirm that the disaggrega-
tion of Ab1-42 performed in our laboratory would produce an
apparently pure monomer preparation (e.g., without detectable
aggregates) with which to initiate the growth of Ab fibrils. Western
blots were performed on Ab specimens subjected to gel electropho-
resis under both reducing/denaturing and native conditions. The
procedure for the reducing/denaturing gel electrophoresis was
reported previously (31). Native gels were generated by electropho-
resing Ab through a 4–20% Tris-HCl Ready Gel (Bio-Rad). Twenty
microliters of an Ab monomer preparation [6 mg/ml, prepared as
described previously (31); total amount added per lane, 0.12 mg] was
mixed with an equal volume of Native Sample Buffer (Bio-Rad),
then loaded into the appropriate lane; 14-kDa, 66-kDa and 132-kDa
standards from Sigma-Aldrich’s Non-Denaturing Molecular Weight
Kit (catalog no. MWND500) were run in additional lanes. The
transfer of proteins to the PVDF membrane and subsequent staining
with mouse monoclonal 6E10 (anti-Ab1-16; Covance Research
Laboratories, Berkeley, CA) were the same as for the reducing/
denaturing gels.
Production of Ab Fibrils: General Procedure
Ab1-42 was resuspended in DMSO (Sigma-Aldrich) to a concen-
tration of 8.1 mg/ml using three eppitubes of previously disaggregated
Ab. Four microliters of DMSO was added to the first eppitube and
water bath- sonicated for 10 min. This was then transferred to the
second tube, and after sonication to the third tube, where it was again
sonicated. The Ab preparation was then diluted to 100 mM (450 mg/ml)
by adding 68 ml of 10 mM HCl, then incubated at 37uC and assayed for
Thioflavin-T reactivity as described below. A growth curve for Ab fibril
formation was initially performed in which Thioflavin-T reactivity was
measured in the Ab preparation and in the negative control tube
(DMSO/HCl) immediately after preparation (day 0) and on days 4 and
7. Based on the results from this experiment, fibrils were grown for
7 days in subsequent experiments.
Irradiation of Ab Fibrils
The effects of radiation on preformed Ab fibrils (produced as
described above) and on the formation of these fibrils were
examined in four types of experiments. Initial experiments involved
exposure of preformed Ab fibrils to 10 Gy, with the Thioflavin-T
assay performed immediately thereafter. Subsequent dose–response
experiments were performed in a similar manner except that Ab
fibrils were exposed to either 5 or 20 Gy. The longer-term effects of
radiation on preformed Ab fibrils were then examined by
irradiating preformed fibrils with 10 Gy, then continuing the
incubation of the Ab preparations at 37uC for an additional 2 or
4 weeks prior to performing the Thioflavin-T assay. The final type
of experiment investigated the influence of radiation on the
formation of Ab fibrils; Ab monomer preparations were irradiated
at time 0 with 10 Gy, then incubated in fibril-promoting conditions
for 1 week, followed by the Thioflavin-T assay. The negative
controls for all experiments were sham-irradiated Ab samples and
vehicle controls (DMSO/HCl) without Ab. Each type of experiment
was performed on at least three separate occasions. The term
‘‘repetition,’’ where used below, will refer to a separate performance
of a type of experiment.
Thioflavin-T Assay
Thioflavin-T (Acros Organics, Fairlawn, NJ) was prepared as a
0.25 mM stock solution (pH 6) in 100 mM sodium phosphate and
100 mM sodium chloride. The solution was stored at 4uC, then
allowed to reach room temperature on the day of the experiment. It
was mixed at a 25:1 ratio with the Ab fibril sample. After vortexing,
the mixture sat at room temperature for 30 min, then was mixed by
trituration and divided into aliquots (100 ml per well) in multiple
wells of a black opaque 96-well culture plate (PerkinElmer,
Waltham, MA). The plate was read at 37uC with excitation at
450 nm and absorption at 485 nm on a Molecular Devices
SpectraMAX Gemini EM microplate spectrofluorometer (Molecular
Devices Corp., Sunnyvale, CA). Softmax Pro Version 5.0 (Molecular
Devices) was used to evaluate the data. The Thioflavin-T reactivity
of Ab fibril preparations in each experiment was measured as
relative fluorescence units; in experiments in which the effects of
radiation on fibrils were examined, the data were expressed as a
percentage of the reactivity of the vehicle control. All samples were
tested in a blinded fashion.
Transmission Electron Microscopy (TEM)
Ab fibrils were grown for 7 days as described above; then 10 Gy-
irradiated and sham-irradiated Ab fibril preparations as well as an Ab
monomer preparation were imaged by TEM using methods described
previously (32). Each sample was spread on a Formvar-coated grid
(Electron Microscopy Sciences, Fort Washington, PA) and incubated
for 2 h at room temperature, then rinsed with double-distilled water.
Samples were then fixed with 1% glutaraldehyde in 100 mM
phosphate buffer, pH 7.4, for 10 min, rinsed again with water, and
stained with 1% uranyl acetate for 10 min and alkaline lead citrate for
5 min. Images were taken with a Morgagni 268 transmission electron
microscope (FEI Company, Hillsboro, OR) equipped with a
Hamamatsu digital camera. The TEM operator was blinded to the
identities of the samples.
Statistics
For statistical analysis of the Ab fibril growth curve, comparisons
of Thioflavin-T reactivity between Ab-containing and negative
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control (DMSO/HCl) tubes were performed on days 0, 4 and 7 by
two-sample t tests. For experiments in which the effects of radiation
were examined on preformed Ab fibrils or on the development of
these fibrils, the distribution of the results from each experiment set
was first analyzed to determine if it met the assumptions of the
proposed statistical tests. The assumption of a normal distribution
was assessed with normal probability plots and the Anderson-
Darling statistic while the assumption of equal variances was
assessed by data plots, the Brown-Forsythe test and the Levene test.
These analyses were performed for the normalized data, which were
obtained by dividing the relative fluorescence units data by the
mean of the negative (vehicle-only) controls for a given experiment.
Standard linear mixed models using restricted maximum likelihood
estimation were used to assess treatment effects when the data were
reasonably consistent with its assumptions (i.e., normal distribution
and equal variances); when there was evidence of unequal variances
across treatments and/or repetitions of an experiment, modifica-
tions to the mixed-model ANOVA that adjust for unequal variances
were considered. For this study, treatment (vehicle controls,
irradiation at a specified dose, and sham irradiation) was
considered fixed while each repetition of an experiment and the
treatment-experimental repetition interaction were considered
random. Least-squares treatment means with their appropriate
standard errors summarized the overall response to each treatment
in each set of experiments. Tukey-Kramer P values and confidence
intervals were used for multiple comparisons of treatments for the
normalized data from the dose–response experiments. Statistical
significance for all analyses was determined using the 0.05 level. The
SAS System for Windows version 9.2 and Minitab Release 14 were
used for this analysis.
RESULTS
Western Blots
Western blots of the freshly disaggregated Ab used for
growing fibrils revealed one band, presumably corre-
sponding to Ab monomer, in both reducing/denaturing
and native gels (Fig. 1).
Ab Fibril Growth Curve
Thioflavin-T reactivity of the Ab fibril preparation was
significantly different from the DMSO/HCl control on
both day 4 (P 5 0.004) and day 7 (P , 0.001) (Fig. 2).
Influence of Radiation on Preformed Ab Fibrils:
Acute Studies
The effects of radiation were initially examined on
preformed (7-day incubated) Ab fibrils by irradiating the
fibrils with 10 Gy, followed immediately by measurement
of Thioflavin-T reactivity. Because preliminary analysis
showed unequal variances, the variance of the assay results
was allowed to vary for each repetition of the experiment.
The means ± SEM for Thioflavin-T reactivity of irradiated
and sham-irradiated fibrils, normalized for background
fluorescence of the vehicle control, are shown in Fig. 3a.
There was no significant difference in Thioflavin-T
reactivity between the two groups [P 5 0.35; 95% CI for
irradiated mean – sham-irradiated mean: (217.27, 7.25)].
A dose–response study was then performed in which
preformed Ab fibrils were exposed to 0 Gy (sham
irradiation), 5 Gy or 20 Gy and then Thioflavin-T
reactivity was evaluated. The experiment was performed
on three separate occasions. There was no evidence of a
difference in mean normalized Thioflavin-T reactivity
among the three groups (P 5 0.817). All of the adjusted
P values for Tukey pairwise comparisons were at least
0.80 [95% Tukey CI for differences: 5 Gy – 20 Gy:
FIG. 1. Western blots of Ab1-42 after disaggregation with
trifluoroacetic acid and hexafluoro-2-propanol prior to its incubation
in fibril-promoting conditions. Lane A, reducing/denaturing gel; lane
B, native gel. Only one band is seen on each gel. The distances of
migration for molecular weight standards are shown for each of the
gels; individual nondenaturing molecular weight standards from
Sigma-Aldrich were used with the native gel. Total protein loaded:
lane A, 0.20 mg; lane B, 0.12 mg.
FIG. 2. Growth curve for Ab1-42 fibrils. Thioflavin-T reactivity is
shown as relative fluorescence units for Ab1-42 incubated in fibril-
promoting conditions and for a vehicle (DMSO/HCl) control.
Reactivity was evaluated immediately after resuspending Ab (day 0)
and at 4 and 7 days. n 5 3–4 wells per time; *P , 0.05 with two-
sample t test compared to MSO/HCl control.
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(28.98, 10.76); 5 Gy – sham-irradiated: (28.06, 11.67);
20 Gy – sham-irradiated: (28.95, 10.78)]. Data are
shown in Fig. 3b.
Influence of Radiation on Preformed Ab Fibrils:
Longer-Term Studies
Preformed (7-day) Ab fibrils were irradiated with
10 Gy or sham-irradiated; then incubation was contin-
ued for 2 and 4 weeks before Thioflavin-T reactivity was
evaluated on these specimens and on the vehicle-only
control. The experiment was performed on three
separate occasions. Statistical analyses were performed
separately for each period. For week 2 data, in each of
the three experiments, the mean of the normalized
Thioflavin-T reactivity was larger for the irradiated
group than for the sham-irradiated group, but this
difference was not statistically significant [P 5 0.114;
95% CI for 10 Gy – sham-irradiated: (23.82, 16.96)].
For week 4 data, there was no indication of a significant
difference in the normalized Thioflavin-T reactivity
between irradiated and sham-irradiated samples [P 5
0.68; 95% CI for 10 Gy – sham-irradiated: (27.21,
5.24)]. Data are shown in Fig. 4.
Influence of Radiation on Development of Ab Fibrils
Freshly disaggregated Ab was irradiated with 10 Gy or
sham-irradiated, then incubated in fibril-promoting con-
ditions for 1 week, followed by measurement of Thiofla-
vin-T reactivity. The experiment was performed on five
separate occasions. Preliminary examination of the data
suggested potential problems with unequal variances
across the treatment-experimental repetition combina-
tions; however, using a more complicated variance
structure did not improve the analysis, so the standard
linear mixed model was used. No significant differences
were found in normalized Thioflavin-T reactivity between
the irradiated and sham-irradiated Ab preparations (P 5
0.62; 95% CI for irradiated – sham-irradiated: (25.21,
7.73)]. Data are shown in Fig. 5.
FIG. 3. Influence of radiation on preformed Ab1-42 fibrils: acute
studies. The effects of radiation on preformed (7-day) Ab fibrils were
examined. Panel a shows Thioflavin-T reactivity of irradiated and
sham-irradiated fibrils immediately after exposure to 10 Gy, and
panel b shows reactivity after exposure to 5 or 20 Gy or sham
irradiation. No significant differences in Thioflavin-T reactivity were
observed between irradiated and sham-irradiated fibrils. Data shown
are least-squares means ± SEM for normalized values (percentage of
vehicle control) and are from four separate repetitions in panel a and
three separate repetitions in panel b.
FIG. 4. Influence of radiation on preformed Ab1-42 fibrils:
longer-term studies. Preformed (7-day) Ab fibrils were irradiated
with 10 Gy or sham-irradiated; incubation was continued for 2 and
4 weeks before Thioflavin-T reactivity was evaluated on these
specimens and on the vehicle-only control. There were no significant
differences in Thioflavin-T reactivity between irradiated and sham-
irradiated fibril preparations at either time. Data shown are least-
squares means ± SEM for normalized values (percentage of vehicle
control) and are from three separate repetitions of this experiment.
FIG. 5. Influence of radiation on development of Ab fibrils.
Freshly disaggregated Ab was irradiated with 10 Gy or sham-
irradiated, then incubated in fibril-promoting conditions for 1 week,
and Thioflavin-T reactivity was evaluated. No significant differences
were found between irradiated and sham-irradiated Ab preparations.
Data shown are least-squares means ± SEM for normalized values
(percentage of vehicle control) and are from five separate repetitions
of this experiment.
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Transmission Electron Microscopy
Extensive fibril formation was observed in both the
nonirradiated and irradiated Ab fibril preparations.
These structures were not seen in the Ab monomer
preparation. Representative TEMs are shown in
Fig. 6a–c.
DISCUSSION
Radiotherapy has been suggested as a potential
treatment for AD based on its effectiveness against
TBA (29). Although these effects are thought to be
primarily due to its toxicity to plasma cells in the trachea
or bronchi, direct degradation of Ab could also be
involved, because radiation’s ability to damage proteins
is well documented (33–35). In this in vitro study, we
found no evidence for direct degradation of preformed
Ab fibrils by external beam radiation or for radiation-
induced impairment of Ab fibril development.
The Thioflavin-T assay is the most frequently used
procedure for monitoring fibril growth (36, 37), and
TEM is commonly used to confirm fibril growth.
Thioflavin-T reactivity is generally reported in arbitrary
fluorescence units, so comparing results between labo-
ratories can be problematic. The dye undergoes a shift in
fluorescence after binding to b-pleated sheet structures,
but the exact mechanism of Thioflavin-T’s binding to
amyloid fibrils is unclear (37). The Thioflavin-T
reactivity in our Ab fibril preparations was often less
than 10% greater than the vehicle control, although the
presence of fibrils was confirmed by TEM. We therefore
performed each experiment on multiple occasions and
used a statistical analysis that considered the data
obtained on these multiple occasions.
Our negative findings suggest that external beam
radiation, when used in our in vitro experimental
paradigm, does not degrade Ab fibrils. However, we
cannot rule out the possibility that radiation may have
induced alterations in Ab below the sensitivity of
detection of the Thioflavin-T assay, although we regard
this as unlikely. Even if radiation does not directly
damage fibrillar Ab, it could still reduce plaque counts
in the AD brain by indirect mechanisms; for example,
radiation-induced inflammation in the brain (38–40)
might increase the clearance of fibrillar Ab by plaque-
associated microglia. Although activated microglia
efficiently phagocytose Ab fibrils and plaques in vitro,
they fail to do so in the AD brain (41). However, even if
radiotherapy does improve phagocytic removal of
plaques, the possible benefits of this approach would
need to be weighed against the potentially damaging
effects of whole-brain radiotherapy such as brain
atrophy (42). Postirradiation complications can include
cognitive deficits (42–45), which may take years to
develop (46–49) and can be induced by low doses of
FIG. 6. TEM images. Extensive growth of fibril-like structures
was present in both nonirradiated (panel a) and irradiated (panel b)
Ab fibril preparations. Fibrils were not seen in the Ab monomer
preparation (panel c). Bar 5 500 nm.
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radiation even without signs of overt tissue damage (50).
The hippocampus, an area of extensive pathology in
AD, is particularly sensitive to radiation-induced injury
(51); in experimental mice, 10 Gy whole-brain irradia-
tion impaired hippocampal-dependent spatial learning
and memory (50, 52). Radiation-induced inflammation
in the brain could also be damaging; CNS inflammatory
processes are already increased in AD (53), and
inflammation has been referred to as a ‘‘double-edged
sword’’ in AD and other neurodegenerative disorders
because of its potential for both neurotoxic and
neuroprotective effects (54).
In conclusion, we found no evidence for direct
degradation of Ab fibrils or for reduced production of
these fibrils by the single doses of external beam
radiation that were examined in this in vitro study.
Although radiotherapy might still reduce plaque counts
in the AD brain by indirect means, the potential dangers
of this approach would need to be considered.
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